 2. Patients must have disease that is not amenable to potentially curative resection or ablative techniques or that has recurred following ablative techniques. In addition, disease must not be amenable to transhepatic arterial chemoembolization TACE or must have progressed on TACE. Patients must not be candidates for liver transplantation. 